| Clinical data | |
|---|---|
| Other names | LY-38851; Lilly 38851; Nandrolone adamantoate; Nandrolone adamantane-1-carboxylate; 19-Nortestosterone 17β-adamantoate |
| Routes of administration | Intramuscular injection |
| Drug class | Androgen;Anabolic steroid;Androgen ester;Progestogen |
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEMBL | |
| CompTox Dashboard(EPA) | |
| Chemical and physical data | |
| Formula | C29H40O3 |
| Molar mass | 436.636 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Bolmantalate (developmental code nameLY-38851 orLilly 38851), also known as19-nortestosterone 17β-adamantoate (ornandrolone adamantoate), is anandrogen andanabolic steroid and anandrolone ester which was synthesized and developed byEli Lilly in 1965 but was never marketed.[1][2]
| Compound | PRTooltip Progesterone receptor | ARTooltip Androgen receptor | ERTooltip Estrogen receptor | GRTooltip Glucocorticoid receptor | MRTooltip Mineralocorticoid receptor | SHBGTooltip Sex hormone-binding globulin | CBGTooltip Corticosteroid-binding globulin |
|---|---|---|---|---|---|---|---|
| Nandrolone | 20 | 154–155 | <0.1 | 0.5 | 1.6 | 1–16 | 0.1 |
| Testosterone | 1.0–1.2 | 100 | <0.1 | 0.17 | 0.9 | 19–82 | 3–8 |
| Estradiol | 2.6 | 7.9 | 100 | 0.6 | 0.13 | 8.7–12 | <0.1 |
| Notes: Values are percentages (%). Referenceligands (100%) wereprogesterone for thePRTooltip progesterone receptor,testosterone for theARTooltip androgen receptor,estradiol for theERTooltip estrogen receptor,dexamethasone for theGRTooltip glucocorticoid receptor,aldosterone for theMRTooltip mineralocorticoid receptor,dihydrotestosterone forSHBGTooltip sex hormone-binding globulin, andcortisol forCBGTooltip corticosteroid-binding globulin.Sources: See template. | |||||||
Thisdrug article relating to thegenito-urinary system is astub. You can help Wikipedia byexpanding it. |
Thisdrug article relating to thegastrointestinal system is astub. You can help Wikipedia byexpanding it. |